Virtual Seminar: Pathways to Recovery from Alcohol Use Disorder
Katie Witkiewitz, Ph.D.
Regents' Professor of Psychology
University of New Mexico
Virtual Pioneers in Biomedical Research Seminar: Pathways to Recovery from Alcohol Use Disorder
Sept. 10, 2021
11:00 a.m. to 12:00 p.m.
Video of the event
About this Seminar
Abstinence from alcohol is often viewed as the most desirable and ideal outcome for individuals with alcohol use disorder. Yet, most individuals with alcohol use disorder do not want to abstain from drinking and do not seek treatment. Over the past 20 years, there have been several significant methodological advances in studying patterns and predictors of alcohol use and drinking reductions, yet most of the work has not had a major influence on clinical practice. Dr. Witkiewitz's talk will provide a broad overview of this literature and present new data on the validity of World Health Organization drinking risk levels as a harm reduction endpoint. Results from several recent studies provide evidence that reductions in World Health Organization drinking risk levels are a viable alternative to abstinence as a public health and harm reduction strategy and as an endpoint for alcohol clinical trials. The talk will also highlight new perspectives and new empirical data examining non-abstinent recovery from alcohol use disorder.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Addiction Recovery Research Center and the Center for Health Behaviors Research. The Pioneers in Biomedical Research Seminar Series, which runs annually from September to May, has featured leading biomedical researchers from throughout the country since the program began in 2012. The lectures are also open to all members of the Virginia Tech community including graduate students, undergraduates, faculty, and staff, as well as the public.
You May Also Be Interested In...
-
Home Item
A Human-Centric View of Cerebellar Development , homeApril 18, 2025, 11:00 a.m. | Kathleen Millen, Ph.D., Professor, Department of Pediatrics/Genetics, Associate Director and Principal Investigator, Seattle Children's Hospital Research Institute, The University of Washington School of Medicine | Co-Sponsored by the Center for Neurobiology Research, Fralin Biomedical Research Institute
-
Home Item
Molecular and Neurobiological Studies in Rett Syndrome and Other MECP2 Disorders , homeMay 1, 2025, 5:30 p.m. (Reception at 5 p.m.) | Huda Zoghbi, M.D., Professor, Pediatrics, Molecular and Human Genetics, Neuroscience, and Neurology; Director, Jan and Dan Duncan Neurological Research Institute, Baylor College of Medicine; Member, National Academy of Medicine | Maury Strauss Distinguished Public Lecture
-
Home Item
A Novel Bispecific Antibody to Target the Brain Tumor Microenvironment , homeMay 2, 2025, 11:00 a.m. | Khuson Yun, Ph.D., Associate Professor, Department of Neurology, Houston Methodist Chair, Neurodegenerative Disease Research, Houston Methodist Research Institute, Weill Cornell Medical College | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – Roanoke
-
Home Item
Transformation of Information from the External World by Cortical Circuits During Learning , homeMay 9, 2025, 11:00 a.m. | Alison Barth, Ph.D., Professor, Department of Biological Sciences, Carnegie Mellon University | Co-Sponsored by the Center for Neurobiology Research, Fralin Biomedical Research Institute
-
Home Item
The Role of Exercise in Memory Function , homeMay 23, 2025, 11:00 a.m. | Henriette van Praag, Ph.D., Associate Professor, Department of Biomedical Science, Charles E. Schmidt College of Medicine, Florida Atlantic University | Co-Sponsored by the Center for Exercise Medicine Research, Fralin Biomedical Research Institute
-
Home Item
Pathways and Regulation of Cardiac Nav1.5 Channel Trafficking in Adult Myocytes , homeMay 30, 2025, 11:00 a.m. | Gea-Ny Tseng, Ph.D., Professor, Department of Physiology and Biophysics, Virginia Commonwealth University School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research